UK markets closed
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • FTSE 250

    19,363.28
    -46.12 (-0.24%)
     
  • AIM

    853.32
    +2.76 (+0.32%)
     
  • GBP/EUR

    1.1646
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2270
    +0.0014 (+0.11%)
     
  • BTC-GBP

    13,944.14
    +24.66 (+0.18%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.88 (+0.10%)
     
  • CRUDE OIL

    80.34
    -0.88 (-1.08%)
     
  • GOLD FUTURES

    1,797.30
    -3.80 (-0.21%)
     
  • NIKKEI 225

    27,777.90
    -448.20 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.05 (-0.33%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • CAC 40

    6,742.25
    -11.72 (-0.17%)
     

Global Stem Cell Assays Market to Reach $4.1 Billion by 2027

ReportLinker
ReportLinker

Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Stem Cell Assays Industry" - https://www.reportlinker.com/p06361331/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Stem Cell Assays Market to Reach $4.1 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Stem Cell Assays estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$4.1 Billion by 2027, growing at a CAGR of 17.7% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 18.2% CAGR and reach US$3.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 17.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $380.1 Million, While China is Forecast to Grow at 16.7% CAGR

The Stem Cell Assays market in the U.S. is estimated at US$380.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$704.3 Million by the year 2027 trailing a CAGR of 16.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.2% and 15.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Services Segment to Record 13.8% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 13.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$114.7 Million in the year 2020 will reach a projected size of US$280.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 44 Featured) -
Antria, Inc.
Applied StemCell, Inc.
Beike Biotechnology Co., Ltd.
BioGenCell
BioRestorative Therapies
Bio-Techne Corporation
Celltex Therapeutics
Century Therapeutics
Cynata Therapeutics Ltd.
Forever Labs, Inc.


Read the full report: https://www.reportlinker.com/p06361331/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Stem Cell Assay - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Cell
Identification by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Cell Identification by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 3: World Recent Past, Current & Future Analysis for
Differentiation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Differentiation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 5: World Recent Past, Current & Future Analysis for
Isolation & Purification by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for Isolation & Purification
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Proliferation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World 7-Year Perspective for Proliferation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 9: World Recent Past, Current & Future Analysis for
Function by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 10: World 7-Year Perspective for Function by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 11: World Recent Past, Current & Future Analysis for
Apoptosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 12: World 7-Year Perspective for Apoptosis by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Adult Stem Cells by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World 7-Year Perspective for Adult Stem Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 15: World Recent Past, Current & Future Analysis for
hESCs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 16: World 7-Year Perspective for hESCs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 17: World Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 18: World 7-Year Perspective for Regenerative Medicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Clinical Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World 7-Year Perspective for Clinical Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 21: World Recent Past, Current & Future Analysis for Drug
Discovery & Development by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 22: World 7-Year Perspective for Drug Discovery &
Development by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2021 & 2027

Table 23: World Stem Cell Assays Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027

Table 24: World Recent Past, Current & Future Analysis for Stem
Cell Assays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 25: World 7-Year Perspective for Stem Cell Assays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2021 & 2027

Table 26: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 27: World 7-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for Kits
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World 7-Year Perspective for Kits by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 30: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 31: World 7-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 32: World Recent Past, Current & Future Analysis for
Viability / Cytotoxicity by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 33: World 7-Year Perspective for Viability / Cytotoxicity
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2022 (E)
Table 34: USA Recent Past, Current & Future Analysis for Stem
Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: USA 7-Year Perspective for Stem Cell Assays by Type -
Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 36: USA Recent Past, Current & Future Analysis for Stem
Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 37: USA 7-Year Perspective for Stem Cell Assays by Cell
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and hESCs for the Years 2021 & 2027

Table 38: USA Recent Past, Current & Future Analysis for Stem
Cell Assays by Application - Regenerative Medicine, Clinical
Research and Drug Discovery & Development - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 39: USA 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 40: USA Recent Past, Current & Future Analysis for Stem
Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: USA 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

CANADA
Table 42: Canada Recent Past, Current & Future Analysis for
Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 43: Canada 7-Year Perspective for Stem Cell Assays by
Type - Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 44: Canada Recent Past, Current & Future Analysis for
Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 45: Canada 7-Year Perspective for Stem Cell Assays by
Cell Type - Percentage Breakdown of Value Sales for Adult Stem
Cells and hESCs for the Years 2021 & 2027

Table 46: Canada Recent Past, Current & Future Analysis for
Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Canada 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 48: Canada Recent Past, Current & Future Analysis for
Stem Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 49: Canada 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

JAPAN
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2022 (E)
Table 50: Japan Recent Past, Current & Future Analysis for Stem
Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 51: Japan 7-Year Perspective for Stem Cell Assays by Type -
Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 52: Japan Recent Past, Current & Future Analysis for Stem
Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 53: Japan 7-Year Perspective for Stem Cell Assays by Cell
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and hESCs for the Years 2021 & 2027

Table 54: Japan Recent Past, Current & Future Analysis for Stem
Cell Assays by Application - Regenerative Medicine, Clinical
Research and Drug Discovery & Development - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 55: Japan 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 56: Japan Recent Past, Current & Future Analysis for Stem
Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 57: Japan 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

CHINA
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2022 (E)
Table 58: China Recent Past, Current & Future Analysis for Stem
Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: China 7-Year Perspective for Stem Cell Assays by Type -
Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 60: China Recent Past, Current & Future Analysis for Stem
Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 61: China 7-Year Perspective for Stem Cell Assays by Cell
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and hESCs for the Years 2021 & 2027

Table 62: China Recent Past, Current & Future Analysis for Stem
Cell Assays by Application - Regenerative Medicine, Clinical
Research and Drug Discovery & Development - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 63: China 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 64: China Recent Past, Current & Future Analysis for Stem
Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

EUROPE
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2022 (E)
Table 66: Europe Recent Past, Current & Future Analysis for
Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 67: Europe 7-Year Perspective for Stem Cell Assays by
Type - Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 68: Europe Recent Past, Current & Future Analysis for
Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 69: Europe 7-Year Perspective for Stem Cell Assays by
Cell Type - Percentage Breakdown of Value Sales for Adult Stem
Cells and hESCs for the Years 2021 & 2027

Table 70: Europe Recent Past, Current & Future Analysis for
Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Europe 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 72: Europe Recent Past, Current & Future Analysis for
Stem Cell Assays by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 73: Europe 7-Year Perspective for Stem Cell Assays by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2021 & 2027

Table 74: Europe Recent Past, Current & Future Analysis for
Stem Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 75: Europe 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

FRANCE
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2022 (E)
Table 76: France Recent Past, Current & Future Analysis for
Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: France 7-Year Perspective for Stem Cell Assays by
Type - Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 78: France Recent Past, Current & Future Analysis for
Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 79: France 7-Year Perspective for Stem Cell Assays by
Cell Type - Percentage Breakdown of Value Sales for Adult Stem
Cells and hESCs for the Years 2021 & 2027

Table 80: France Recent Past, Current & Future Analysis for
Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 81: France 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 82: France Recent Past, Current & Future Analysis for
Stem Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: France 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

GERMANY
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2022 (E)
Table 84: Germany Recent Past, Current & Future Analysis for
Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 85: Germany 7-Year Perspective for Stem Cell Assays by
Type - Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 86: Germany Recent Past, Current & Future Analysis for
Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 87: Germany 7-Year Perspective for Stem Cell Assays by
Cell Type - Percentage Breakdown of Value Sales for Adult Stem
Cells and hESCs for the Years 2021 & 2027

Table 88: Germany Recent Past, Current & Future Analysis for
Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Germany 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 90: Germany Recent Past, Current & Future Analysis for
Stem Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 91: Germany 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

ITALY
Table 92: Italy Recent Past, Current & Future Analysis for Stem
Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 93: Italy 7-Year Perspective for Stem Cell Assays by Type -
Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 94: Italy Recent Past, Current & Future Analysis for Stem
Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Italy 7-Year Perspective for Stem Cell Assays by Cell
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and hESCs for the Years 2021 & 2027

Table 96: Italy Recent Past, Current & Future Analysis for Stem
Cell Assays by Application - Regenerative Medicine, Clinical
Research and Drug Discovery & Development - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 97: Italy 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 98: Italy Recent Past, Current & Future Analysis for Stem
Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 99: Italy 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

UNITED KINGDOM
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2022 (E)
Table 100: UK Recent Past, Current & Future Analysis for Stem
Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: UK 7-Year Perspective for Stem Cell Assays by Type -
Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 102: UK Recent Past, Current & Future Analysis for Stem
Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 103: UK 7-Year Perspective for Stem Cell Assays by Cell
Type - Percentage Breakdown of Value Sales for Adult Stem Cells
and hESCs for the Years 2021 & 2027

Table 104: UK Recent Past, Current & Future Analysis for Stem
Cell Assays by Application - Regenerative Medicine, Clinical
Research and Drug Discovery & Development - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 105: UK 7-Year Perspective for Stem Cell Assays by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 106: UK Recent Past, Current & Future Analysis for Stem
Cell Assays by Component - Instruments, Kits and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: UK 7-Year Perspective for Stem Cell Assays by
Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

REST OF EUROPE
Table 108: Rest of Europe Recent Past, Current & Future
Analysis for Stem Cell Assays by Type - Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 109: Rest of Europe 7-Year Perspective for Stem Cell
Assays by Type - Percentage Breakdown of Value Sales for
Viability / Cytotoxicity, Differentiation, Isolation &
Purification, Cell Identification, Proliferation, Function and
Apoptosis for the Years 2021 & 2027

Table 110: Rest of Europe Recent Past, Current & Future
Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells
and hESCs - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 111: Rest of Europe 7-Year Perspective for Stem Cell
Assays by Cell Type - Percentage Breakdown of Value Sales for
Adult Stem Cells and hESCs for the Years 2021 & 2027

Table 112: Rest of Europe Recent Past, Current & Future
Analysis for Stem Cell Assays by Application - Regenerative
Medicine, Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Rest of Europe 7-Year Perspective for Stem Cell
Assays by Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 114: Rest of Europe Recent Past, Current & Future
Analysis for Stem Cell Assays by Component - Instruments, Kits
and Services - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 115: Rest of Europe 7-Year Perspective for Stem Cell
Assays by Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

ASIA-PACIFIC
Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2022 (E)
Table 116: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 117: Asia-Pacific 7-Year Perspective for Stem Cell Assays
by Type - Percentage Breakdown of Value Sales for Viability /
Cytotoxicity, Differentiation, Isolation & Purification, Cell
Identification, Proliferation, Function and Apoptosis for the
Years 2021 & 2027

Table 118: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: Asia-Pacific 7-Year Perspective for Stem Cell Assays
by Cell Type - Percentage Breakdown of Value Sales for Adult
Stem Cells and hESCs for the Years 2021 & 2027

Table 120: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 121: Asia-Pacific 7-Year Perspective for Stem Cell Assays
by Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Stem Cell Assays by Component - Instruments, Kits and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 123: Asia-Pacific 7-Year Perspective for Stem Cell Assays
by Component - Percentage Breakdown of Value Sales for
Instruments, Kits and Services for the Years 2021 & 2027

REST OF WORLD
Table 124: Rest of World Recent Past, Current & Future Analysis
for Stem Cell Assays by Type - Viability / Cytotoxicity,
Differentiation, Isolation & Purification, Cell Identification,
Proliferation, Function and Apoptosis - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 125: Rest of World 7-Year Perspective for Stem Cell
Assays by Type - Percentage Breakdown of Value Sales for
Viability / Cytotoxicity, Differentiation, Isolation &
Purification, Cell Identification, Proliferation, Function and
Apoptosis for the Years 2021 & 2027

Table 126: Rest of World Recent Past, Current & Future Analysis
for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 127: Rest of World 7-Year Perspective for Stem Cell
Assays by Cell Type - Percentage Breakdown of Value Sales for
Adult Stem Cells and hESCs for the Years 2021 & 2027

Table 128: Rest of World Recent Past, Current & Future Analysis
for Stem Cell Assays by Application - Regenerative Medicine,
Clinical Research and Drug Discovery & Development -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 129: Rest of World 7-Year Perspective for Stem Cell
Assays by Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Clinical Research and Drug Discovery &
Development for the Years 2021 & 2027

Table 130: Rest of World Recent Past, Current & Future Analysis
for Stem Cell Assays by Component - Instruments, Kits and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Rest of World 7-Year Perspective for Stem Cell

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06361331/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001